Als Co-Autor mit Prof. Gün­ter Kampf

In 2020 and 2021, 56.2% of hos­pi­ta­li­zed COVID-19 cases in Ger­ma­ny were cate­go­ri­zed with the prin­ci­pal dia­gno­sis of an acu­te lower respi­ra­to­ry tract infec­tion. In the mean­ti­me, howe­ver, appro­xi­m­ate­ly 95% of the Ger­man popu­la­ti­on have IgG anti­bo­dies against the S‑antigen. At the same time, the omic­ron vari­ant of SARS-CoV‑2 beca­me domi­nant with a lower patho­ge­ni­ci­ty resul­ting in a redu­ced risk for inten­si­ve care tre­at­ment and mecha­ni­cal ven­ti­la­ti­on. Both deve­lo­p­ments may result in a lower bur­den of acu­te respi­ra­to­ry tract infec­tion among hos­pi­ta­li­zed COVID-19 cases. That is why we ana­ly­zed the renu­me­ra­ti­on data of the natio­nal health insu­ran­ces in Ger­ma­ny (Janu­ary 2020–September 2022) pro­vi­ded by the Insti­tu­te for the Hos­pi­tal Renu­me­ra­ti­on System.

Wei­ter­le­sen in Infec­tion

Anmer­kung: Die Inhal­te die­ses Bei­trags wur­den zuvor in einem Bei­trag auf Mul­ti­po­lar veröffentlicht.

Als Co-Autor mit Prof. Gün­ter Kampf

It was recent­ly descri­bed that the over­all risk of myope­ri­car­di­tis after recei­ving a
COVID-19 vac­ci­ne is low, except for youn­ger males recei­ving mRNA vac­ci­nes [1]. The
meta-ana­ly­sis was based on obser­va­tio­nal stu­dies on peo­p­le in the gene­ral popu­la­ti­on
who had myope­ri­car­di­tis in tem­po­ral rela­ti­on to recei­ving vac­ci­nes [1]. In order to deter-
mine if the­se fin­dings were sup­port­ed by the case num­bers in Ger­ma­ny, we eva­lua­ted the
num­ber of hos­pi­ta­li­sed cases, inclu­ding tho­se recei­ving inten­si­ve-care tre­at­ment, with
myo­car­di­tis or peri­car­di­tis befo­re the pan­de­mic (2019), during the pan­de­mic but wit­hout
COVID-19 vac­ci­nes (2020), and during the pan­de­mic with COVID-19 vac­ci­nes (2021).

Wei­ter­le­sen im Jour­nal of Cli­ni­cal Medicine

Anmer­kung: Die Inhal­te die­ses Bei­trags wur­den zuvor in einem Bei­trag auf Mul­ti­po­lar veröffentlicht.

Als Co-Autor mit Prof. Gün­ter Kampf

The offi­ci­al num­ber of hos­pi­ta­li­zed COVID-19 cases based on the World Health Orga­niza­ti­on defi­ni­ti­on (a per­son with con­firm­ed detec­tion of SARS-CoV‑2) is used in public health report­ing and may have major impli­ca­ti­ons on public health mea­su­res. But the defi­ni­ti­on may not ade­qua­te­ly descri­be whe­ther pati­ents were admit­ted for COVID-19 or if the prin­ci­pal dia­gno­sis was ano­ther dise­a­se and the pati­ent acqui­red COVID-19 in the hos­pi­tal or was tes­ted posi­ti­ve for SARS-CoV‑2 during the hos­pi­tal stay wit­hout any respi­ra­to­ry tract sym­ptoms. That is why we ana­ly­sed the remu­ne­ra­ti­on data of the natio­nal health insu­ran­ces during the first three COVID-19 waves in Ger­ma­ny (Janu­ary 2020―May 2021) pro­vi­ded by the Insti­tu­te for the Hos­pi­tal Remu­ne­ra­ti­on System.

Wei­ter­le­sen im Inter­na­tio­nal Jour­nal of Epidemiology

Anmer­kung: Die Inhal­te die­ses Bei­trags wur­den zuvor in einem Bei­trag auf Mul­ti­po­lar veröffentlicht.